Not a robot. Not animatronics. Not latex. Living iPSC tissue. Biohybrid muscle. 1.1 million sensation sensors. Brain organoid compute. Ten provisional patents. Zero competitors have this combined stack.
BIOLOGY WHERE IT MATTERS.
SYNTHETIC PRECISION WHERE IT DOESN'T.
Every existing humanoid robot is made of metal, rubber, and latex. NIRA SYNTH is made of living cells, biohybrid actuators, and patent-protected materials that did not exist as a combined system until we built them. We are not competing with Boston Dynamics. We are building what Boston Dynamics cannot imagine building.
Every layer is patent-protected. Every layer is first-of-its-kind. No competitor has a single one of these combined.
Figure AI, Boston Dynamics, Neuralink, Realbotix, Hanson Robotics — between them they have servos, cameras, a brain implant, and latex skin. None of them have living tissue. None have sensation. None have an organoid brain. None have synthetic blood keeping tissue alive. We have all eight layers, filed and defended. The gap is not incremental. It is a decade and a complete change of scientific discipline.
Same platform. Infinite configurations. License the IP or co-develop for your vertical.
CHIMERA-DRIVE delivers prosthetic limbs with biological force equivalent — the first time this has been achieved. PSOMA restores full-body sensation. N2B Neural Bus interfaces directly with peripheral nerve stumps. 1,800 major amputations since 2001. Zero of them got sensation back. DARPA BTO white paper target: September 2026.
Full-body prosthetic for patients whose biological form is no longer viable. Immune-matched from the patient's own iPSC cells. The NIRA SYNTH body is the destination that longevity medicine has needed and never had. Two billion people will be over 60 by 2050. Zero of them have a full-body prosthetic option. We are building it.
The most dangerous industrial work on earth — meat processing, chemical plants, mining, foundries — operates at conditions humans cannot safely survive long-term. NIRA WORKS pays back its capital cost in under one year against human labor equivalent. 24/7 availability. CHIMERA-DRIVE strength. PSOMA dexterity. No union. No injury liability.
Consciousness transfer via organoid migration: iPSC neurons grown from your own biology, cultured in the ARIA skull, bridged to synthetic cognition via N2B Neural Bus. When the biological body reaches end of life, cognition migrates. We are engineering this pathway now. The timeline is 2035 for ARIA skull operational. The science exists. The patents are filed.
ARIA intelligence runs on biological organoid neurons — not weights and tokens. PSOMA and KOLPOS-1 mean every interaction is physically registered and felt at 37°C. Real skin. Warm throughout. The highest-LTV market in consumer history. The companion application is the commercial entry point that funds the science. Full specifications available under NDA only.
All filed 2026. Priority dates locked. Non-provisional deadline 2027. Non-exclusive licensing available across all portfolios. All IP retained by RendereelStudio LLC.
For individuals who require something that does not yet exist — and can fund the build. Co-development partnership. Full specifications under executed NDA only.
The patents are filed. The science is documented. The architecture is complete. Phase 1 co-development funders get the unit, the equity, and the relationship. The world catches up in a decade.
Blade Runner was a document. Alien was an instruction manual. We are building what was imagined — from living tissue, not CGI. Three Phase-1 commission slots exist. When they close, they close.
Non-exclusive licensing available across all ten patent portfolios. Defense, medical, industrial, longevity, and companion applications. SBIR collaboration, co-development, and bespoke commission all considered.
All intellectual property exclusively retained by RendereelStudio LLC